Cargando…

Shared-care survivorship program for testicular cancer patients: safe and feasible

BACKGROUND: Testicular cancer survivors are at risk for cardiovascular disease, often preceded by early development of cardiovascular risk factors due to chemotherapeutic treatment. Therefore, close collaboration between oncologists and primary care physicians (PCPs) is needed during follow-up to mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Boer, H., Lubberts, S., Bunskoek, S., Nuver, J., Lefrandt, J.D., Steursma, G., Sluiter, W.J., Siesling, S., Berendsen, A.J., Gietema, J.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271504/
https://www.ncbi.nlm.nih.gov/pubmed/35576694
http://dx.doi.org/10.1016/j.esmoop.2022.100488
_version_ 1784744694666756096
author Boer, H.
Lubberts, S.
Bunskoek, S.
Nuver, J.
Lefrandt, J.D.
Steursma, G.
Sluiter, W.J.
Siesling, S.
Berendsen, A.J.
Gietema, J.A.
author_facet Boer, H.
Lubberts, S.
Bunskoek, S.
Nuver, J.
Lefrandt, J.D.
Steursma, G.
Sluiter, W.J.
Siesling, S.
Berendsen, A.J.
Gietema, J.A.
author_sort Boer, H.
collection PubMed
description BACKGROUND: Testicular cancer survivors are at risk for cardiovascular disease, often preceded by early development of cardiovascular risk factors due to chemotherapeutic treatment. Therefore, close collaboration between oncologists and primary care physicians (PCPs) is needed during follow-up to monitor and manage cardiovascular risk factors. We designed a shared-care survivorship program, in which testicular cancer patients visit both their oncologist and their PCP. The objective of this study was to test the safety and feasibility of shared-care follow-up after treatment for metastatic testicular cancer. PATIENTS AND METHODS: The study was designed as an observational cohort study with a stopping rule to check for the safety of follow-up. Safety boundaries were defined for failures in the detection of signals indicating cancer recurrence. Secondary outcomes were the proportion of carried out cardiovascular risk assessments, psychosocial status and patient preferences measured with an evaluation questionnaire. RESULTS: One hundred and sixty-two patients were enrolled (69% of eligible testicular cancer patients). Almost all (99%, n = 150) PCPs of the enrolled patients agreed to participate in the study. In total, 364 primary care visits took place. No failures occurred in the detection of relapsed testicular cancer. Four follow-up visits were considered as failures because of organizational issues, without activation of the stopping rule. Eventually, the safe boundary was crossed indicating that this shared-care model is a safe alternative for follow-up after testicular cancer. Patients were satisfied with the knowledge level of PCPs. PCPs were willing to further extend their role in follow-up care after cancer. CONCLUSIONS: Shared-care follow-up is safe and feasible in this patient population. Patients benefit from personalized care, partly close to their home. Within shared care, PCPs can have an important role in cardiovascular risk management and psychosocial survivorship issues.
format Online
Article
Text
id pubmed-9271504
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92715042022-07-12 Shared-care survivorship program for testicular cancer patients: safe and feasible Boer, H. Lubberts, S. Bunskoek, S. Nuver, J. Lefrandt, J.D. Steursma, G. Sluiter, W.J. Siesling, S. Berendsen, A.J. Gietema, J.A. ESMO Open Original Research BACKGROUND: Testicular cancer survivors are at risk for cardiovascular disease, often preceded by early development of cardiovascular risk factors due to chemotherapeutic treatment. Therefore, close collaboration between oncologists and primary care physicians (PCPs) is needed during follow-up to monitor and manage cardiovascular risk factors. We designed a shared-care survivorship program, in which testicular cancer patients visit both their oncologist and their PCP. The objective of this study was to test the safety and feasibility of shared-care follow-up after treatment for metastatic testicular cancer. PATIENTS AND METHODS: The study was designed as an observational cohort study with a stopping rule to check for the safety of follow-up. Safety boundaries were defined for failures in the detection of signals indicating cancer recurrence. Secondary outcomes were the proportion of carried out cardiovascular risk assessments, psychosocial status and patient preferences measured with an evaluation questionnaire. RESULTS: One hundred and sixty-two patients were enrolled (69% of eligible testicular cancer patients). Almost all (99%, n = 150) PCPs of the enrolled patients agreed to participate in the study. In total, 364 primary care visits took place. No failures occurred in the detection of relapsed testicular cancer. Four follow-up visits were considered as failures because of organizational issues, without activation of the stopping rule. Eventually, the safe boundary was crossed indicating that this shared-care model is a safe alternative for follow-up after testicular cancer. Patients were satisfied with the knowledge level of PCPs. PCPs were willing to further extend their role in follow-up care after cancer. CONCLUSIONS: Shared-care follow-up is safe and feasible in this patient population. Patients benefit from personalized care, partly close to their home. Within shared care, PCPs can have an important role in cardiovascular risk management and psychosocial survivorship issues. Elsevier 2022-05-13 /pmc/articles/PMC9271504/ /pubmed/35576694 http://dx.doi.org/10.1016/j.esmoop.2022.100488 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Research
Boer, H.
Lubberts, S.
Bunskoek, S.
Nuver, J.
Lefrandt, J.D.
Steursma, G.
Sluiter, W.J.
Siesling, S.
Berendsen, A.J.
Gietema, J.A.
Shared-care survivorship program for testicular cancer patients: safe and feasible
title Shared-care survivorship program for testicular cancer patients: safe and feasible
title_full Shared-care survivorship program for testicular cancer patients: safe and feasible
title_fullStr Shared-care survivorship program for testicular cancer patients: safe and feasible
title_full_unstemmed Shared-care survivorship program for testicular cancer patients: safe and feasible
title_short Shared-care survivorship program for testicular cancer patients: safe and feasible
title_sort shared-care survivorship program for testicular cancer patients: safe and feasible
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271504/
https://www.ncbi.nlm.nih.gov/pubmed/35576694
http://dx.doi.org/10.1016/j.esmoop.2022.100488
work_keys_str_mv AT boerh sharedcaresurvivorshipprogramfortesticularcancerpatientssafeandfeasible
AT lubbertss sharedcaresurvivorshipprogramfortesticularcancerpatientssafeandfeasible
AT bunskoeks sharedcaresurvivorshipprogramfortesticularcancerpatientssafeandfeasible
AT nuverj sharedcaresurvivorshipprogramfortesticularcancerpatientssafeandfeasible
AT lefrandtjd sharedcaresurvivorshipprogramfortesticularcancerpatientssafeandfeasible
AT steursmag sharedcaresurvivorshipprogramfortesticularcancerpatientssafeandfeasible
AT sluiterwj sharedcaresurvivorshipprogramfortesticularcancerpatientssafeandfeasible
AT sieslings sharedcaresurvivorshipprogramfortesticularcancerpatientssafeandfeasible
AT berendsenaj sharedcaresurvivorshipprogramfortesticularcancerpatientssafeandfeasible
AT gietemaja sharedcaresurvivorshipprogramfortesticularcancerpatientssafeandfeasible